top of page

Evidence and References



Satoshi Ōmura and William C. Campbell won the Nobel Prize for discovering Ivermectin.

An analysis of several observational studies (OBS) and randomized controlled trials (RCT) indicates that prophylaxis and treatment of

COVID-19 with Ivermectin is significantly effective.



















Use of Ivermectin in the

Prophylaxis and Treatment of COVID-19


Front-Line COVID-19 Critical Care Alliance (FLCCC)

          1)  Inhibits the replication of many viruses, including SARS-CoV-2, influenza, and others

          2)  Has potent anti-inflammatory properties with multiple mechanisms of inhibition

          3)  Diminishes viral load and protects against organ damage in animal models

          4)  Prevents transmission of COVID-19 when taken either pre- or post-exposure

          5)  Hastens recovery and decreases hospitalization and mortality in patients with COVID-19

          6)  Leads to far lower case-fatality rates in regions with widespread use




Peru: decrease in deaths after IVM treatments began in Summer 2020

increase in deaths when IVM was restricted in November 2020

                                Chamie-Quintero, J., Hibberd, J. A., & Scheim, D. (March 8, 2021).




Three important summaries of the COVID-19 disease situation, process and its treatment are provided in these videos by


         Dr. Paul Marik, Chief of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School


         Dr. Pierre Kory and Juan Chamie: Effective Use of Ivermectin in South America


         Dr. Darrel DeMello, a family practitioner who has treated more than 6000 COVID-19 patients





IVM appears to have significant efficacy for millions of chronic ("long hauler") COVID-19 patients 

Resources for long haulers can be found at:–-A-Guide-to-the-Management-of-COVID-19.pdf  


Five recent RCTs that confirm major, statistically significant benefits of ivermectin against COVID-19 

Mexico City Study Ivermectin-based Home Kits with Drastic Reduction in Hospitalizations

COVID-19 in Children

Early identification of COVID-19 symptoms in children is described at:  

A COVID-19 outpatient treatment protocol for children is included on the TREATMENTS page of this website.


A Guide to Home-Based COVID Treatment

COVID-19 Review 1.31.2021

Dr. Blaine White, Wayne State University 

COVID-19 & Ivermectin Playlist (Whiteboard Doctor)

COVID-19 Videos (Dr. Mobeen Syed)

COVID-19 Studies for HCQ, IVM, Zinc, Vit D, LY-CoV, Regeneron, Remdesivir

Nutrient therapy to supplement conventional medical therapy for COVID-19 (Dr. Atsuo Yanagisawa)

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)

Overview Of COVID-19: Virology, Pathogenesis, Symptoms, Labs, Transmission, Treatment, Long Haulers

How Ivermectin Works Against COVID-19

Ivermectin COVID-19 Clinical Trials

Ivermectin for COVID-19: meta analysis of studies

Ivermectin and Blood Clotting

Ivermectin and Hydroxychloroquine for COVID-19: Head to Head Comparison

U.S. Senate Committee on Homeland Security and Governmental Affairs  Nov 19, 2020 
Hearing Title: Early Outpatient Treatment: An Essential Part of a COVID-19 Solution

Ambulatory Treatment of COVID-19 (Peter McCullough, MD)

COVID-19 Management

COVID-19 Outpatient Management

Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment

Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic

Ivermectin Triple Therapy Protocol for COVID-19 

Trial of Combination Therapy to Treat COVID-19 Infection


Ivermectin Moves Towards Mainstream   


Dominican Republic Study: Ivermectin 

Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients: A randomized multi-center clinical trial



Early treatment with hydroxychloroquine: a country-based analysis

HCQ is effective for COVID-19 when used early: analysis of 118 studies

Hydroxychloroquine for treating COVID-19  


Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

Hydroxychloroquine and azithromycin plus zinc in hospitalized COVID-19 patients

Inhaled Nebulized Budesonide Therapy for COVID-19

Long Haulers: Ivermectin Treatment

Vaccine Challenges



Rapid In-Home Self-Administered Inexpensive COVID-19 Tests

"These tests are available and with FDA authorization and support could suppress the COVID-19 outbreak and make a country much safer" Michael Mina, MD Ph.D. Assistant Professor of Epidemiology, Immunology, and Infectious Diseases at Harvard University School of Public Health (Sept 2020)


IVM Meta.jpg
Peru 3.21.2021.jpg


This information is provided as a not-for-profit public service by people who are not medical professionals.

In no event shall we or our affiliates be liable for any special, incidental or consequential damages arising out of or in connection with this information or website, including negligence.  


bottom of page